https://www.nature.com/articles/d41586-023-02528-2
0
0
8/10/23 at 1:07pm
Organization
Nature.com
Authors
Clinical-trial data suggest that semaglutide, sold under the name Wegovy, slashes risk of heart attacks and other cardiovascular incidents.
Create an account
or login to join the discussion